Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BHV-1300 in Graves' Disease
NCT07661056Phase 3Recruiting
- Sponsor
- Biohaven Ltd.
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Countries
- 3
01
Overview
A Phase 3 trial of BHV-1300 in Graves' disease, sponsored by Biohaven Ltd.. Started Jun 2026; status: recruiting.
02
Drugs
BHV-1300
03
Conditions
Graves' disease
Beyond the preview
Go deeper on NCT07661056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07661056.